about
Role of ribosomal protein mutations in tumor development (Review)Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsProfiling of 2'-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity.p53, a translational regulator: contribution to its tumour-suppressor activity.In vitro translation in a hybrid cell free lysate with exogenous cellular ribosomes.Ribosome biogenesis is dynamically regulated during osteoblast differentiation.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ribosomes: the future of targeted therapies?
@en
Ribosomes: the future of targeted therapies?
@nl
type
label
Ribosomes: the future of targeted therapies?
@en
Ribosomes: the future of targeted therapies?
@nl
prefLabel
Ribosomes: the future of targeted therapies?
@en
Ribosomes: the future of targeted therapies?
@nl
P2860
P356
P1433
P1476
Ribosomes: the future of targeted therapies?
@en
P2093
Jean-Jacques Diaz
Virginie Marcel
P2860
P304
P356
10.18632/ONCOTARGET.1511
P407
P577
2013-10-01T00:00:00Z